-
1
-
-
48249110446
-
-
a) K. Y. Lee, J. N. Kim, J. M. Kim, Tetrahedron Lett. 2003, 44, 6131.
-
(2003)
Tetrahedron Lett
, vol.44
, pp. 6131
-
-
Lee, K.Y.1
Kim, J.N.2
Kim, J.M.3
-
2
-
-
0037434036
-
-
b) K. Y. Lee, J. M. Kim, J. N. Kim, Tetrahedron 2003, 59, 385.
-
(2003)
Tetrahedron
, vol.59
, pp. 385
-
-
Lee, K.Y.1
Kim, J.M.2
Kim, J.N.3
-
3
-
-
0037189133
-
-
c) Y. J. Im, K. Y. Lee, T. H. Kim, J. N. Kim, Tetrahedron Lett. 2002, 43, 4675.
-
(2002)
Tetrahedron Lett
, vol.43
, pp. 4675
-
-
Im, Y.J.1
Lee, K.Y.2
Kim, T.H.3
Kim, J.N.4
-
5
-
-
0035914494
-
-
b) J. N. Kim, H. S. Kim, J. H. Gong, Y. M. Chung, Tetrahedron Lett. 2001, 42, 8341.
-
(2001)
Tetrahedron Lett
, vol.42
, pp. 8341
-
-
Kim, J.N.1
Kim, H.S.2
Gong, J.H.3
Chung, Y.M.4
-
9
-
-
0021921867
-
-
a) H. M. R. Hoffmann, J. Rabe, Angew. Chem., Int. Ed. Engl. 1985, 24, 94.
-
(1985)
Angew. Chem., Int. Ed. Engl
, vol.24
, pp. 94
-
-
Hoffmann, H.M.R.1
Rabe, J.2
-
11
-
-
37049095518
-
-
c) F. Ameer, S. E. Drewes, R. Hoole, P. T. Kaye, A. T. Pitchford, J. Chem. Soc., Perkin Trans. 1 1985, 2713.
-
(1985)
J. Chem. Soc., Perkin Trans. 1
, pp. 2713
-
-
Ameer, F.1
Drewes, S.E.2
Hoole, R.3
Kaye, P.T.4
Pitchford, A.T.5
-
12
-
-
0037366617
-
-
D. Basavaiah, A. J. Rao, T. Satyanarayana, Chem. Rev. 2003, 103, 811.
-
(2003)
Chem. Rev
, vol.103
, pp. 811
-
-
Basavaiah, D.1
Rao, A.J.2
Satyanarayana, T.3
-
14
-
-
0030436367
-
-
S. S. Korgaokar, P. H. Patil, M. T. Shah, H. M. Parekh, Indian Pharm. Sci. 1996, 58, 222.
-
S. S. Korgaokar, P. H. Patil, M. T. Shah, H. M. Parekh, Indian Pharm. Sci. 1996, 58, 222.
-
-
-
-
15
-
-
3843130908
-
-
J. H. Ahn, H. M. Kim, S. H. Jung, S. K. Kang, K. R. Kim, S. D. Rhee, S. D. Yang, H. G. Cheon, S. S. Kim, Bioorg. Med. Chem. Lett. 2004, 14, 4461.
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, pp. 4461
-
-
Ahn, J.H.1
Kim, H.M.2
Jung, S.H.3
Kang, S.K.4
Kim, K.R.5
Rhee, S.D.6
Yang, S.D.7
Cheon, H.G.8
Kim, S.S.9
-
16
-
-
0032265027
-
-
R. H. Udupi, A. R. Kushnoor, A. R. Bhat, Indian J. Heterocycl. Chem. 1998, 8, 63.
-
(1998)
Indian J. Heterocycl. Chem
, vol.8
, pp. 63
-
-
Udupi, R.H.1
Kushnoor, A.R.2
Bhat, A.R.3
-
17
-
-
0027501729
-
-
A. A. Bilgin, E. Paska, R. Sunal, Arzneim.-Forsch. 1993, 43, 1041.
-
(1993)
Arzneim.-Forsch
, vol.43
, pp. 1041
-
-
Bilgin, A.A.1
Paska, E.2
Sunal, R.3
-
18
-
-
34547092686
-
-
a) M. A. Ali, M. S. Yar, M. Kumar, G. S. Pandian, Nat. Prod. Res. 2007, 21, 575.
-
(2007)
Nat. Prod. Res
, vol.21
, pp. 575
-
-
Ali, M.A.1
Yar, M.S.2
Kumar, M.3
Pandian, G.S.4
-
20
-
-
0343081482
-
-
c) Ş. G. Küçükgüzel, S. Rollas, H. Erdeniz, M. Kiraz, A. C. Ekinci, A. Vidin, Eur. J. Med. Chem. 2000, 35, 761.
-
(2000)
Eur. J. Med. Chem
, vol.35
, pp. 761
-
-
Küçükgüzel, S.G.1
Rollas, S.2
Erdeniz, H.3
Kiraz, M.4
Ekinci, A.C.5
Vidin, A.6
-
21
-
-
0016803946
-
-
d) A. A. Santilli, D. H. Kim, F. J. Gregory, J. Pharm. Sci. 1975, 64, 1057.
-
(1975)
J. Pharm. Sci
, vol.64
, pp. 1057
-
-
Santilli, A.A.1
Kim, D.H.2
Gregory, F.J.3
-
22
-
-
33745180244
-
-
e) M. Shaharyar, A. A. Siddiqui, M. A. Ali, D. Sriram, P. Yogeeswari, Bioorg. Med. Chem. Lett. 2006, 16, 3947.
-
(2006)
Bioorg. Med. Chem. Lett
, vol.16
, pp. 3947
-
-
Shaharyar, M.1
Siddiqui, A.A.2
Ali, M.A.3
Sriram, D.4
Yogeeswari, P.5
-
23
-
-
33746196499
-
-
f) M. Shaharyar, A. A. Siddiqui, M. A. Ali, Bioorg. Med. Chem. Lett. 2006, 16, 4571.
-
(2006)
Bioorg. Med. Chem. Lett
, vol.16
, pp. 4571
-
-
Shaharyar, M.1
Siddiqui, A.A.2
Ali, M.A.3
-
24
-
-
33847145098
-
-
g) M. A. Ali, M. Shaharyar, A. A. Siddiqui, Eur. J. Med. Chem. 2007, 42, 268.
-
(2007)
Eur. J. Med. Chem
, vol.42
, pp. 268
-
-
Ali, M.A.1
Shaharyar, M.2
Siddiqui, A.A.3
-
25
-
-
48249126948
-
-
In two-step sequence, isolated yields of the oxidized Baylis-Hillman adducts were found to be low. This may be attributed towards the high reactivity of the oxidized product of Baylis-Hillman adducts
-
In two-step sequence, isolated yields of the oxidized Baylis-Hillman adducts were found to be low. This may be attributed towards the high reactivity of the oxidized product of Baylis-Hillman adducts.
-
-
-
-
26
-
-
48249140800
-
-
4 and evaporated. The crude reaction mixture was purified by column chromatography using hexane:ethyl acetate (9:1) as eluent to afford pure pyrazolines.
-
4 and evaporated. The crude reaction mixture was purified by column chromatography using hexane:ethyl acetate (9:1) as eluent to afford pure pyrazolines.
-
-
-
|